Rybelsus for Teens: Evidence, Eligibility, Coverage
No. Rybelsus is not approved for anyone under 18. It is approved for adults only: type 2 diabetes and heart risk. In STEP TEENS, BMI fell 16.1% on average for people on Wegovy, vs 0.6% on placebo.
- For teens
- Adults only
- Active ingredient
- semaglutide
- How it is taken
- daily tablet
- Best result (STEP TEENS)
- 16.1% drop in BMI
Rybelsus: quick facts
Its half-life is about 1 week. After 7 d, half is gone, and after five half-lives (35 d), about 3% remains.
In PIONEER 1, people with type 2 diabetes lost 3.7 kg over 26 weeks, while those on placebo lost 1.4 kg.
The maker's price page lists monthly price points in US dollars for the list price and self-pay offers.
Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.
Who qualifies?
| Source | Who qualifies |
|---|---|
| FDA label | For adults with type 2 diabetes, this medicine lowers blood sugar when used with diet and exercise. |
| FDA label | For high-risk adults with type 2 diabetes, it lowers the risk of heart attack, stroke, or heart-related death. |
Sources: FDA label (DailyMed).
Trial results for teens
No trial of Rybelsus itself is part of this group. The trials here study other brands that use the same ingredient.
| Trial | Medicine | Who took part | Length | People | Main result | Comparison |
|---|---|---|---|---|---|---|
| STEP TEENS | Teens aged 12 to 17 with obesity | 68 weeks | 201 | 16.1% drop in BMI | 0.6% on placebo |
Source of the study: STEP TEENS (PubMed).
What is different for teens?
| What changes | What the label says |
|---|---|
| Acute Pancreatitis | Can cause inflammation of the pancreas. Get care and stop taking it when severe stomach pain continues. |
| Acute Gallbladder Disease | Gallstones and gallbladder inflammation can happen. A fever, yellow skin or eyes, or upper-right belly pain should be reported. |
The FDA label (DailyMed) provides the label information.
Warnings in the label come from the FDA label at DailyMed.
Coverage for teens
Alternatives for teens
| Medicine | For teens | How it is taken | Trial result |
|---|---|---|---|
| From age 12, for weight loss | weekly injection or daily tablet | 16.1% drop in BMI | |
| From age 10, for type 2 diabetes | weekly injection | Not listed | |
| From age 10, for type 2 diabetes | weekly injection | Not listed | |
| From age 12, for weight loss | daily injection | Not listed | |
| From age 10, for type 2 diabetes | daily injection | Not listed | |
| Adults only | daily tablet | Not listed | |
| Adults only | weekly injection | Not listed | |
| Adults only | weekly injection | Not listed | |
| Adults only | daily tablet | Not listed | |
| Byetta | Adults only | twice-daily injection | Not listed |
References: FDA label at DailyMed, PubMed.
Questions to ask your prescriber
- Is my child old enough for this medicine based on its label?
- How will growth and eating be checked?
- What would happen if my child wanted to stop taking it?
Read the full Rybelsus prescribing information on DailyMed.